1,2,3,4,5-Pentabromo-6-chlorocyclohexane - CAS 87-84-3
Catalog number: 87-84-3
Category: Main Product
Molecular Formula:
C6H6Br5Cl
Molecular Weight:
513.08
COA:
Inquire
Purity:
95%
Appearance:
White solid.
Synonyms:
1,2,3,4,5-pentabromo-6-chloro-cyclohexan; 1,2,3,4,5-pentabromo-6-chlorocyclohexane; 1,2,3,4,5-pentabromo-6-chlorocyclohexane.; 1-chloro-2,3,4,5,6-pentabromo-cyclohexan; chloropentabromocyclohexane; FR-651A; Cyclohexane, 1,2,3,4,5-pentabromo-6-chloro-; 1,2,3,4-p
MSDS:
Inquire
Quantity:
Data not available, please inquire.
Boiling Point:
338.048ºC at 760 mmHg
Density:
2.706g/cm3
1.Development assistance for health: past trends, associations, and the future of international financial flows for health.
Dieleman JL1, Schneider MT2, Haakenstad A3, Singh L2, Sadat N2, Birger M2, Reynolds A2, Templin T2, Hamavid H2, Chapin A2, Murray CJ2. Lancet. 2016 Apr 12. pii: S0140-6736(16)30168-4. doi: 10.1016/S0140-6736(16)30168-4. [Epub ahead of print]
BACKGROUND: Disbursements of development assistance for health (DAH) have risen substantially during the past several decades. More recently, the international community's attention has turned to other international challenges, introducing uncertainty about the future of disbursements for DAH.
2.Never giving up: outcomes and presentation of emergency general surgery in geriatric octogenarian and nonagenarian patients.
Shah AA1, Zafar SN2, Kodadek LM3, Zogg CK4, Chapital AB5, Iqbal A2, Greene WR2, Cornwell EE 3rd2, Havens J4, Nitzschke S4, Cooper Z4, Salim A4, Haider AH6. Am J Surg. 2016 Mar 19. pii: S0002-9610(16)30117-9. doi: 10.1016/j.amjsurg.2016.01.021. [Epub ahead of print]
BACKGROUND: Aging of the population necessitates consideration of the increasing number of older adults requiring emergency care. The objective of this study was to compare outcomes and presentation of octogenarian and/or nonagenarian emergency general surgery (EGS) patients with younger adults.
3.Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: A multi-national cohort.
Rodger MA1, Scarvelis D2, Kahn SR3, Wells PS2, Anderson DA4, Chagnon I5, Le Gal G2, Gandara E2, Solymoss S6, Sabri E2, Kovacs MJ7. Thromb Res. 2016 Mar 29. pii: S0049-3848(16)30087-1. doi: 10.1016/j.thromres.2016.03.028. [Epub ahead of print]
BACKGROUND: Choosing short-term (3-6 months) or indefinite anticoagulation after a first unprovoked venous thromboembolic event (VTE) is a common and difficult clinical decision. The long-term absolute risk of recurrent VTE after a first unprovoked VTE, in all patients and sub-groups, is not well established, hindering decision making.
4.Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study.
Beesley VL1, Wockner LF2, O'Rourke P2, Janda M3, Goldstein D4,5, Gooden H6, Merrett ND7,8, O'Connell DL9, Rowlands IJ10, Wyld DK11,12, Neale RE2. Support Care Cancer. 2016 Apr 16. [Epub ahead of print]
PURPOSE: This study aims to determine if the supportive care needs of people with pancreatic cancer change over time and identify the factors associated with current and future unmet needs.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


Chemical Structure

CAS 87-84-3 1,2,3,4,5-Pentabromo-6-chlorocyclohexane

Quick Inquiry

Verification code

Featured Items